Navigation Links
AEterna Zentaris completes management team with the appointment of Chief Medical Officer
Date:8/19/2007

QUEBEC CITY, Aug. 16 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the filling of a key position completing the management team with the appointment of Paul Blake, M.D., as Senior Vice President and Chief Medical Officer.

"The appointment of Dr. Blake is timely and critical as our foremost priority is to bring our flagship product candidate, cetrorelix, to market as a novel treatment in the BPH indication in an expeditious manner", said David J. Mazzo, Ph.D., President and Chief Executive Officer at AEterna Zentaris. "Paul brings a wealth of knowledge and is an excellent addition to our team, with over 25 years of solid experience in clinical development and product launching for major pharmaceutical companies worldwide. He will be instrumental in effectively managing our development programs through to commercialization, specifically our Phase 3 program in BPH for cetrorelix, as well as focusing on our other high priority drug development programs."

Prior to joining AEterna Zentaris, Dr. Blake was Chief Medical Officer of Avigenics, Inc. In 2005, he was Senior Vice President, Clinical Research and Regulatory Affairs at Cephalon, Inc. before being promoted to Executive Vice President, Worldwide Medical & Regulatory Operations. From 1992 to 1998, he held the position of Senior Vice President and Medical Director, Clinical Research and Development at SmithKline Beecham Pharmaceuticals (now GSK).

Dr. Blake earned a medical degree from the London University, Royal Free Hospital. He was elected Fellow of the American College of Clinical Pharmacology, Fellow of the Faculty of Pharmaceutical Medicine, Royal College of Physicians in the UK, and is a Fellow of the Royal College of Physicians in the UK.

"Over the recent months, we have made significant progress in strengthening our core competencies and have undeniably establi
'/>"/>

SOURCE AETERNA ZENTARIS INC.

Copyright©2007 PR Newswire.

Page: 1 2 3

Related biology technology :

1. Sonic Foundry completes $11.25M stock offer
2. Orion Energy completes $5M capital round
3. RedPrairie completes MARC acquisition
4. Metavante completes purchase of check processing firm
5. GE completes $1.2 billion acquisition
6. M & Is Metavante completes Brasfield Corp. acquisition
7. Metavante completes GHR Systems acquisition
8. Metavante completes TREEV acquisition
9. Johnson Controls completes sale of French unit
10. OpGen completes $5 million investment round
11. UW Hospital completes deployment of error-reducing technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 2014 Hussey Copper , a leader ... antimicrobial copper, announces Gilmour Academy Ice Arena,s conversion of ... antimicrobial solid touch surface to help protect against bacteria.  ... surface that kills greater than 99.9% of MRSA, E-coli ... , Innovative ...
(Date:9/17/2014)... , Sept. 17, 2014 Veracyte, ... diagnostics company pioneering the field of molecular cytology, today ... operating officer. Mr. Hall joined Veracyte in ... commercial entry into endocrinology. Since 2012, he has led ... as managed care and billing functions. As chief operating ...
(Date:9/17/2014)... 2014 Beckman Coulter , a ... healthcare, has renewed its agreement with Personify ... the agreement, Personify will continue to streamline the Beckman ... recruitment analytics, including time-to-fill, time-to-source and a deep reduction ... with Personify was based on the success of our ...
(Date:9/17/2014)... NASA’s MESSENGER has just celebrated its 10 year ... have one of its latch valves, V27200-818, operating onboard ... investigation of the planet Mercury. It is only the ... provided a vast amount of information and images of ... utilize solenoids that also include permanent magnets to maintain ...
Breaking Biology Technology:Innovative Gilmour Academy Ice Arena changes more than 200 fixtures to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 2Innovative Gilmour Academy Ice Arena changes more than 200 fixtures to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 3Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 2Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 3Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 4Beckman Coulter Signs 3-year RPO Contract with Personify 2Beckman Coulter Signs 3-year RPO Contract with Personify 3
... mounting that genetic factors play an important role in many ... 2, 2011, online in the Journal of Neuroscience , ... Switzerland report a new mammalian model for studying a specific ... to new drugs to fight the malady. , "This is ...
... Professor of Physics and Engineering Physics at Stevens Institute ... Foundation (NSF) with the prestigious CAREER Award. One of ... CAREER Award supports early career development of faculty in ... researchers and teachers. The awards provide a financial stipend ...
... Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA ... commercialization of products for central nervous system disorders, today ... of 2010, on Thursday, February 10, 2011, before the ... will be disseminated at that time. Mihael ...
Cached Biology Technology:A new model for studying Parkinson's 2Dr. Stefan Strauf of physics at Stevens receives NSF CAREER Award for quantum research 2Dr. Stefan Strauf of physics at Stevens receives NSF CAREER Award for quantum research 3Vanda Pharmaceuticals to Announce Fourth Quarter 2010 Financial Results on February 10, 2011 2
(Date:9/16/2014)... Schizophrenia is associated with increased rates and intensity of ... that the relationship between schizophrenia and smoking stems, in ... to self-medicate symptoms and cognitive impairment associated with the ... issue of Biological Psychiatry , sheds light on ... nicotine receptors in the brain was lower in schizophrenia ...
(Date:9/16/2014)... What motivates consumers to make ethical choices such as ... more money on fair-trade coffee, and bringing their own ... study in the Journal of Consumer Research , ... to turn their emotions about unethical practices into action. ... consider the environmental and human costs of the products ...
(Date:9/16/2014)... RALEIGH, N.C. , Sept. 16, 2014  Valencell, ... has been chosen as one of 18 "Showcase Companies" ... technology businesses at the annual CED Tech Venture Conference ... Raleigh Convention Center in Raleigh, ... LeBoeuf will lead a discussion during the "Digital ...
Breaking Biology News(10 mins):Smoking and schizophrenia linked by alterations in brain nicotine signals 2Why are consumers willing to spend more money on ethical products? 2Valencell, Inc. Selected as 'Showcase Company' at CED Tech Venture Conference 2014 2
... to help stem the global HIV epidemic is to ... the drug tenofovir) before they have high risk sex ... infected, an approach called "pre-exposure prophylaxis" (PREP). But activist ... at least two important clinical trials of tenofovir as ...
... have pinpointed circuitry in the brains of monkeys that ... Their findings -- gained from experiments in which they ... juice rewards -- could give insights into why humans ... drug use and overeating. , The researchers, Michael Platt ...
... fruit fly have found a family of proteins that enhances ... trigger abnormal growth and cancer. Their discovery could lead to ... development of new drugs to stop uncontrolled growth in a ... University of Oxford, funded in part by the Biotechnology and ...
Cached Biology News:Why were the HIV prevention trials in commercial sex workers abandoned? 2Gambling monkeys give insight into neural machinery of risk 2Gambling monkeys give insight into neural machinery of risk 3Gambling monkeys give insight into neural machinery of risk 4Fruit fly studies open new window on cancer research 2
... The loxP-amp-loxP cassette is ... cells. The prokaryotic promoter gb2 driving ... slightly modified version of the Em7 promoter. ... generally used Tn5 promoter. A synthetic polyadenylation ...
... PRO S-7 stirrers deliver accurate ... channels fluids away from internal ... easy-to-use controls which allow users ... ceramic tops feature a chemical ...
... AMPure is a magnetic bead-based ... no sample transfer, centrifugation or ... small and large PCR extension ... microplates. Agencourt AMPure can easily ...
... These 1.5L PYREX trypsinizing flasks ... tissue samples into cell suspensions ... Heavy beaded neck accepts cotton ... vigorous agitation. • Height of ...
Biology Products: